Arash Hossein-Nezhad, MD, PhD

Research Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Arash Hossein-nezhad, MD, PhD is a Research Assistant Professor of Endocrinology, Diabetes & Nutrition at Boston University. Dr. Hossein-nezhad is a multidisciplinary scientist with a background in human and molecular genetics, nutrition, endocrinology, cancer, immunology and bioinformatics focused on epigenetic researches. He has extensive experience in research with over 100 peer reviewed publications as well as experience in other research and clinical areas such as bone clinic, microarray and CGH array, liquid chromatography tandem mass spectroscopy, real time PCR, circulating miRNA and microvesicles, Elisa, stem cells and tissue engineering, and next generation sequencing.

Publications

  • Published 2/19/2025

    Shirvani P, Shirvani A, Holick MF. Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrome: A Scoping Review Bridging Cellular Energetics and Genetic Pathways. Curr Issues Mol Biol. 2025 Feb 19; 47(2). PMID: 39996855.

    Read at: PubMed

  • Published 2/14/2025

    Shirvani A, Shirvani P, Jonah U, Moore BE, Holick MF. Suspected Mitochondrial Dysfunction and Complex Pathophysiology in Fatal Hypermobile Ehlers-Danlos Syndrome: Insights from a Case Report and Post-Mortem Findings. Biomedicines. 2025 Feb 14; 13(2). PMID: 40002882.

    Read at: PubMed

  • Published 10/17/2024

    Shirvani P, Shirvani A, Holick MF. Decoding the Genetic Basis of Mast Cell Hypersensitivity and Infection Risk in Hypermobile Ehlers-Danlos Syndrome. Curr Issues Mol Biol. 2024 Oct 17; 46(10):11613-11629. PMID: 39451569.

    Read at: PubMed

  • Published 5/10/2024

    Maghbooli Z, Shirvani A, Moghadasi AN, Varzandi T, Hamtaei Ghashti S, Sahraian MA. Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple sclerosis patients: A randomized, double-blind clinical trial- a pilot study. Mult Scler Relat Disord. 2024 Jul; 87:105673. PMID: 38759424.

    Read at: PubMed

  • Published 2/8/2024

    Rafiee S, Hossein-Nezhad A, Maghbooli Z, Zargaran A, Emamgholipour S, Ghasemi A, Ahmadi M, Esmaeeli H, Karimi M. Effect of Padzahr Tablet on Biochemical Indices of Bone Remodeling in Postmenopausal Females with Osteopenia: A Randomized Double-Blind Placebo-Controlled Trial. Galen Med J. 2024; 13:1-10. PMID: 39554395.

    Read at: PubMed

Education

  • Tehran University, MD/PhD